The Operating Revenue of Jinbo Bio-Pharmaceutical for 2023 Reaching 0.78 Billion yuan  

出　　处：《China Detergent & Cosmetics》2024年第2期5-5,共1页日用化学品科学（英文版）

摘　　要：In Mar.20th,2024,Jinbo Bio-Pharmaceutical released the first performance report since it was listed at Beijing Stock Exchange,with many data hitting a record high.The company realized an operating revenue of 0.78 billion yuan,with a year-on-year increase of 99.96%,and hitting a new high for the past five years.The net profit attributable to shareholders was 0.3 billion yuan,with a year-on-year increase of 174.6%.The net profit attributable to shareholders after deducting non recurring gains and losses was 0.286 billion yuan,with a year-on-year increase of 181.02%.

关 键 词：REVENUE LISTED JIN 

分 类 号：F426.7[经济管理—产业经济] F832.51